PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
18-Apr-2023 Avance Clinical CEO Joins Global BioPharma Panel for Evolution Europe Summit 2023 Avance Clinical
13-Apr-2023 atai Life Sciences Announces First Subject Dosed in the Phase 1 IV-to-Subcutaneous Bridging Study of PCN-101 (R-Ketamine) atai Life Sciences
12-Apr-2023 Almirall, the first to assess wellbeing in a dermatology clinical study Almirall
11-Apr-2023 Phastar Supports Great Ormond Street Rare Disease Study Through Pro Bono Scheme Phastar
11-Apr-2023 Australia’s Paradigm Biopharmaceuticals says phase 2 trial in osteoarthritis shows signs of disease modification at 6-month follow-up Paradigm Biopharmaceuticals
11-Apr-2023 TrialWire Patient Recruitment Platform Launches AI Pre-recruit to Cut Recruitment Time by 50% TrialWire
10-Apr-2023 CD Bioparticles Launches Normal Phase Chromatography Resins for Chromatographic Analysis CD Bioparticles
10-Apr-2023 CD BioSciences Launches Fluorescence Correlation Spectroscopy CD BioSciences
10-Apr-2023 CD BioSciences Introduces Various Solutions for Studying Apoptotic Cell Death CD BioSciences
10-Apr-2023 Creative Diagnostics Introduces Virus Yield Reduction Assay Service Creative Diagnostics
10-Apr-2023 Creative Diagnostics Introduces New Low Endotoxin Antibodies for Researchers Creative Diagnostics
07-Apr-2023 CD Bioparticles Launches mRNA Transfection Reagents for Research Applications CD Bioparticles
05-Apr-2023 Endogena Therapeutics Completes Dose Escalation in the Phase 1/2a Clinical Trial of EA-2353 for the Treatment of Retinitis Pigmentosa Endogena Therapeutics
05-Apr-2023 CluePoints Announces Amit Patel as New CFO CluePoints
05-Apr-2023 Greenphire Appoints Steve Geffon as Chief Commercial Officer Greenphire
30-Mar-2023 Clinical Study of TISSIUM’s COAPTIUM Connect Atraumatic Sutureless Nerve Coaptation System Is Underway in Australia TISSIUM
30-Mar-2023 Modus Therapeutics secures access to bridge financing from longstanding investor Karolinska Development Modus Therapeutics
30-Mar-2023 AlzeCure presents new data at Alzheimer’s conference AD/PD on the potential disease-modifying effect of NeuroRestore ACD856 AlzeCure
30-Mar-2023 Immutep announces expansion of triple combination therapy in first-line non-small cell lung cancer Immutep
30-Mar-2023 AskBio to Present Phase 1b Results Investigating AB-1005 (formerly AAV2-GDNF) as Treatment for Parkinson’s Disease at AD/PDTM 2023 International Conference on Alzheimer's and Parkinson's Diseases Asklepios BioPharmaceutical, Inc